Cyclosporin A-induced cell kill in vitro in various clinical-hematological types of B-cell chronic lymphocytic leukemia.
- 14 September 2000
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 24 (10) , 805-812
- https://doi.org/10.1016/s0145-2126(00)00050-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A transformed view of cyclosporineNature, 1999
- Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemiaLeukemia Research, 1998
- Comparison between Anthracyclines and Rhodamine-123 Accumulation in Chronic Lymphoid Leukemia: Effect of Cyclosporin A and VerapamilTumor Biology, 1998
- Effect of Cyclosporin A in a Patient with Refractory Nephrotic Syndrome Associated with B Chronic Lymphocytic LeukemiaNephron, 1996
- Pure red cell aplasia and cyclosporineAmerican Journal of Hematology, 1995
- Cyclosporin a Inhibits Cytokine-Induced Proliferation in B-Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1994
- Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.Journal of Clinical Pathology, 1989
- Cyclosporin‐A therapy of pure red cell aplasia in a patient with B‐cell chronic lymphocytic leukemiaEuropean Journal of Haematology, 1989
- Cyclosporin‐a for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemiaAmerican Journal of Hematology, 1987
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981